What is Trialbee?
Founded in 2010, Trialbee operates at the intersection of software engineering and life sciences. The company provides a sophisticated, cloud-based platform designed to streamline the clinical trial process, which is historically characterized by fragmentation and communication silos. By facilitating seamless collaboration between sponsors, clinical research organizations, and patient recruitment networks, Trialbee addresses the core bottlenecks that often delay drug development timelines. Their market position is defined by a commitment to digital transformation in healthcare, enabling stakeholders to optimize patient engagement and data management through a unified, intuitive interface.
How much funding has Trialbee raised?
Trialbee has raised a total of $20.3M across 3 funding rounds:
Unspecified
$3.3M
Series A
$5M
Other Financing Round
$12M
Unspecified (2013): $3.3M, investors not publicly disclosed
Series A (2015): $5M led by Industrifonden
Other Financing Round (2020): $12M supported by Briban Invest AB and MTIP AG
Key Investors in Trialbee
Industrifonden
A prominent Swedish venture capital firm that specializes in backing scalable innovations within deep tech and life sciences, providing long-term support to transformative ventures.
Briban Invest AB
A private investment firm focused on supporting growth-stage companies with a particular interest in technology-driven solutions that offer significant market disruption.
MTIP AG
A Swiss-based health-tech investment firm that partners with digital health companies to accelerate their growth and improve the efficiency of healthcare delivery systems.
What's next for Trialbee?
With the recent influx of capital, Trialbee is well-positioned to scale its enterprise-level operations and expand its footprint in the global clinical research market. The strategic focus will likely center on enhancing the platform's predictive analytics capabilities and deepening integration with existing electronic health record systems. As the industry shifts toward decentralized clinical trials, Trialbee's ability to provide a robust, collaborative framework will be essential for maintaining competitive advantage. The company is expected to prioritize talent acquisition and international market penetration, leveraging its established reputation to capture a larger share of the multi-billion dollar clinical trial software market.
See full Trialbee company page
